Great result with the over-subscription & $40m now raised.
One thing i dont fully understand yet though is this -
"Importantly, the funds raised will cover the forecast costs of the Phase IIb & Phase III trials."
While yes $40m is alot of money, but with all the comparisons made with DNDN how is PRR able to complete Phase III with $40M when Dendreon raised much much larger amounts (many multiples) to carry through to end point ?
Great result with the over-subscription & $40m now raised.One...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $407.2M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.5¢ | 27.3¢ | $118.0K | 423.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 365576 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 83749 | 9 |
View Market Depth
| Last trade - 11.50am 04/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |